A Comparative Study of Three Sclerosing Agents in the Treatment of Telangiectasias

Sclerotherapy is advisable for the treatment of superficial varicosities and telangiectasias (3,4,5,8). None of the sclerosing agents is ideal and all can cause damage to the skin (1,2,3,6). Most frequently we find hyperpigmentation (24–35%), secondary telangiectasias (11–16%), superficial necrosis and/or ulcers (0–3%) and dark permanent skin changes (1–3%) (1,2,6,7).